Updated on: 26 February 2024

Roles in: Methods Board, Co-ordinating Editors' Board, Patient Reported Outcomes Alliance, Cancer Alliance, Editorial Board

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in any topic covered in the Cochrane Library?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Providing independent medical consultation professional services to the Reformulary Group.

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
Yes - PT is an independent committee member for a clinical trial Data Safety Monitoring Boards for FDA approved trial, funded by UCB Biopharma GmbH & SPRL and co-ordinated by Parexel International. He is an an advisory committee member of the Canadian Reformulary Group Inc., a company that reviews the evidence for health insurance companies employer drug plans.

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by, or do you or they own, a commercial organization with a financial interest in any topic covered in the Cochrane Library?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in any topic covered in the Cochrane Library?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to any topic covered in the Cochrane Library?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - I am [unpaid] Chair of the Management Group of a registered non-profit independent medical research organization, OMERACT, whose goal is to improve and advance the health outcomes for patients suffering from musculoskeletal conditions. OMERACT receives arms-length funding from 11 companies (Abbvie, Astra Zenaca, Aurinia, BMS, Centrexion, GSK, Horizon Pharma Inc , Janssen, Novartis, Pfizer & Sparrow).